Found: 9
Select item for more details and to access through your institution.
Increased Presence of FOXP3<sup>+</sup> Regulatory T Cells in Inflamed Muscle of Patients with Active Juvenile Dermatomyositis Compared to Peripheral Blood.
- Published in:
- PLoS ONE, 2014, v. 9, n. 8, p. 1, doi. 10.1371/journal.pone.0105353
- By:
- Publication type:
- Article
Epigenetic changes in inflammatory arthritis monocytes contribute to disease and can be targeted by JAK inhibition.
- Published in:
- Rheumatology, 2023, v. 62, n. 8, p. 2887, doi. 10.1093/rheumatology/kead001
- By:
- Publication type:
- Article
Methotrexate treatment affects effector but not regulatory T cells in juvenile idiopathic arthritis.
- Published in:
- Rheumatology, 2015, v. 54, n. 9, p. 1724, doi. 10.1093/rheumatology/kev101
- By:
- Publication type:
- Article
m 6 A Reader YTHDC1 Impairs Respiratory Syncytial Virus Infection by Downregulating Membrane CX3CR1 Expression.
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 5, p. 778, doi. 10.3390/v16050778
- By:
- Publication type:
- Article
N 6 -Methyladenosine Directly Regulates CD40L Expression in CD4 + T Lymphocytes.
- Published in:
- Biology (2079-7737), 2023, v. 12, n. 7, p. 1004, doi. 10.3390/biology12071004
- By:
- Publication type:
- Article
N<sup>6</sup>-methyladenosine promotes TNF mRNA degradation in CD4<sup>+</sup> T lymphocytes.
- Published in:
- Journal of Leukocyte Biology, 2024, v. 116, n. 4, p. 807, doi. 10.1093/jleuko/qiae087
- By:
- Publication type:
- Article
Reversal of Sepsis‐Like Features of Neutrophils by Interleukin‐1 Blockade in Patients With Systemic‐Onset Juvenile Idiopathic Arthritis.
- Published in:
- Arthritis & Rheumatology, 2018, v. 70, n. 6, p. 943, doi. 10.1002/art.40442
- By:
- Publication type:
- Article
Self-Sustained Resistance to Suppression of CD8+ Teff Cells at the Site of Autoimmune Inflammation Can Be Reversed by Tumor Necrosis Factor and Interferon-γ Blockade.
- Published in:
- Arthritis & Rheumatology, 2016, v. 68, n. 1, p. 229, doi. 10.1002/art.39418
- By:
- Publication type:
- Article
Recombinant Interleukin‐1 Receptor Antagonist Is an Effective First‐Line Treatment Strategy in New‐Onset Systemic Juvenile Idiopathic Arthritis, Irrespective of HLA‐DRB1 Background and IL1RN Variants.
- Published in:
- Arthritis & Rheumatology, 2024, v. 76, n. 1, p. 119, doi. 10.1002/art.42656
- By:
- Publication type:
- Article